Concepedia

Author

Matthew O’Rourke

Cincinnati Children's Hospital Medical Center

Also Known As

Matthew J. O'Rourke, Matthew O'Rourke, Matthew O’Rourke

9

Publications

1.1K

Citations

6

H-Index

19

Concepts

All Affiliations

Cincinnati Children's Hospital Medical CenterUniversity of PennsylvaniaColumbia University
MO

About

Matthew O’Rourke is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, urology, and nephrology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

356

2

Nephrology

2

2

356

3

Public Health

1

1

20

4

Emergency Medicine

1

1

336

5

Newborn Medicine

1

1

20

Matthew O’Rourke

×

6

Publications

1.1K

Citations

6

H-Index

YearCitations

Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase–Associated Lipocalin for Diagnosing Acute Kidney Injury

Thomas L. Nickolas, Matthew O’Rourke, Jun Yang,

Annals of Internal Medicine

2008

677

Diagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage

Thomas L. Nickolas, Kai M. Schmidt‐Ott, Pietro A. Canetta,

Journal of the American College of Cardiology

2012

336

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CTL019) in Conjunction with Salvage Autologous Stem Cell Transplantation for Advanced Multiple Myeloma

Alfred L. Garfall, Edward A. Stadtmauer, Marcela V. Maus,

Blood

2016

34

Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease

Ahmad Kaddourah, Susan Uthup, Peace C. Madueme,

Clinical Nephrology

2015

22

Reference Range of Urinary Neutrophil Gelatinase-Associated Lipocalin in Very Low-Birth-Weight Infants: Preliminary Data

Elvira Parravicini, John M. Lorenz, Sheri L. Nemerofsky,

American Journal of Perinatology

2009

20

First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma

Edward A. Stadtmauer, Adam D. Cohen, Kristy Weber,

Blood

2019

14

Page 1